Skip to main content

Month: April 2021

Kratos XQ-58A Valkyrie Successfully Completes Sixth Flight, Including First Payload Release from Internal Weapons Bay

SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ:KTOS), a leading National Security Solutions provider, announced today that the Air Force Research Laboratory, in partnership with Kratos Unmanned Systems Division and Area-I, successfully completed the XQ-58A Valkyrie’s sixth test/demonstration flight and first release from its internal weapons bay on Friday, March 26, 2021, at Yuma Proving Ground, Arizona. A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b066c8aa-614e-4484-9620-f2543f510d80 Steve Fendley, President of Kratos Unmanned Systems Division, said, “Successful operation of the internal weapons release system/function along with further aerodynamic envelope increases continues to assert the incredible capability and...

Continue reading

Vyant Bio Announces Newly Appointed Board of Directors

CHERRY HILL, N.J., April 05, 2021 (GLOBE NEWSWIRE) — Vyant Bio, Inc. (the “Company”) (Nasdaq: VYNT), is a new force in drug discovery, focused on integrating human-powered scientific and technology-based systems to de-risk and accelerate the discovery of therapeutics for biopharma partners as well as for the proprietary pipeline of the Company. Its newly formed Board of Directors comes from the disciplines of drug discovery and development, pharmaceuticals, and life science strategy and finance. The new board members bring decades of experience and leadership to help guide the Company in its focus on innovative and market leading drug discovery. The Company is led in the executive suite by Jay Roberts, Chief Executive Officer, Ping Yeh, Chief Innovation Officer and Andy LaFrence, Chief Financial Officer. Joining Mssrs. Roberts and...

Continue reading

Navient to announce first quarter 2021 results on April 27, host earnings call on April 28

WILMINGTON, Del., April 05, 2021 (GLOBE NEWSWIRE) — Navient (Nasdaq: NAVI), a leading provider of education loan management and business processing solutions, today announced it will release its 2021 first quarter financial results on Navient.com/investors after market close on Tuesday, April 27, 2021. Navient will host a conference call to review results on Wednesday, April 28, 2021 at 8 a.m. ET. Navient will notify investors when earnings results have been issued by a news release over a wire service. In addition, the earnings results will also be filed with the Securities and Exchange Commission on Form 8-K, which will be available on the SEC website. To access the conference call, dial 855-838-4156 (USA and Canada) or 267-751-3600 (international) and use access code 1291876 starting at 7:45 a.m. ET. The live audio webcast will...

Continue reading

Queensberry Mining and Development Corp. Acquires Additional Shares of St. Augustine Gold and Copper Limited

LAS PINAS CITY, Philippines, April 05, 2021 (GLOBE NEWSWIRE) — Queensberry Mining and Development Corp. (“Queensberry”) is pleased to announce that on April 5, 2021, it acquired 70,176,859 common shares (the “Shares”) of St. Augustine Gold and Copper Limited (“SAU”), a Philippines based mineral exploration company focusing on the acquisition, exploration and evaluation of mineral properties. The Shares were acquired upon the conversion of approximately CAD$3,232,167.25 (USD$2,554,265.25) of debt owed by SAU to Queensberry (the “Debt Conversion”) at a deemed price of CAD$0.046057 per Share. Queensberry acquired 70,176,859 Shares representing approximately 9.65% of the issued and outstanding Shares (on a non-diluted basis). Immediately prior to the Debt Conversion, Queensberry owned 218,500,000 Shares (representing approximately 30.07%...

Continue reading

Duck Creek Technologies Announces Second Quarter Fiscal 2021 Financial Results

Second Quarter Fiscal 2021 Subscription revenue grew 51% year-over-year SaaS Annual Recurring Revenue grew 75% year-over-yearBOSTON, April 05, 2021 (GLOBE NEWSWIRE) — Duck Creek Technologies (NASDAQ: DCT), a provider of SaaS-delivered enterprise software to the property & casualty (“P&C”) insurance industry, today announced its financial results for the three and six months ended February 28, 2021. “Duck Creek delivered strong second quarter results, as our continued market momentum drove 51% subscription revenue growth,” said Michael Jackowski, Duck Creek’s Chief Executive Officer. “Our growing number of SaaS wins, across all segments of the market, highlights that Duck Creek OnDemand can successfully scale from solutions for regional insurers to serving as the global platform for the most demanding Tier 1 Insurers.”                                                                                                                                    Mr....

Continue reading

TopBuild Completes Acquisition of American Building Systems

DAYTONA BEACH, Fla., April 05, 2021 (GLOBE NEWSWIRE) — TopBuild Corp. (NYSE:BLD), a leading installer and distributor of insulation and building material products in the United States, has successfully completed its acquisition of American Building Systems (“ABS”), announced on March 1, 2021, following the expiration of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976. Robert Buck, President and Chief Executive Officer of TopBuild, stated, “We welcome the ABS team to TopBuild and expect that our combined company will continue to serve ABS’ customer base and provide enhanced product offerings, services, and capabilities. Our teams have been working together to ensure a smooth transition as we integrate ABS into TopBuild’s systems and operations.” ABS, a residential insulation and distribution business,...

Continue reading

Bonanza Creek Energy Announces 2021 Guidance

DENVER, April 05, 2021 (GLOBE NEWSWIRE) — Bonanza Creek Energy, Inc. (NYSE: BCEI) (the “Company” or “Bonanza Creek”) today announced 2021 guidance, and has posted an updated investor presentation to its website. Highlights Include:Total 2021 annual capital expenditures are expected to be between $150 and $170 million 2Q – 4Q 2021 production guidance of 40.0 to 44.0 thousand barrels of oil equivalent per day (“MBoe/d”) Full year pro forma 2021 estimated production of approximately 42.0 MBoe/d(1) 2Q – 4Q 2021 oil production guidance of 48% to 52% of BOE volumes Leverage ratio at closing of approximately 0.5x (pro forma net debt / pro forma LTM EBITDAX) Expect to generate over $150 million of full year 2021 estimated levered free cash flow at current strip pricing(2)(1)   Assumes mid-point of...

Continue reading

Metacrine Appoints Dr. Julia C. Owens to Its Board of Directors

SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced the appointment of Julia C. Owens, Ph.D. to the Company’s board of directors, effective April 1, 2021. Dr. Owens will serve as a member of the Compensation Committee.   “We’re excited to welcome Julia as a new independent director,” commented Richard Heyman, Ph.D., Metacrine’s chairman. “She is an accomplished biopharmaceutical executive, with an established track record in building companies, business development, capital formation and strategic partnerships. Julia’s perspective will provide our board with valuable insights as we look ahead to important operating and clinical development milestones.”      Dr....

Continue reading

Prothena Announces Appointment of Hideki Garren, MD, PhD, as Chief Medical Officer

DUBLIN, Ireland, April 05, 2021 (GLOBE NEWSWIRE) — Prothena Corporation plc (NASDAQ:PRTA), a late-stage clinical company with expertise in protein dysregulation and a pipeline of investigational therapeutics for rare peripheral amyloid and neurodegenerative diseases, today announced the appointment of Hideki Garren, MD, PhD, as Chief Medical Officer. Dr. Garren will lead the clinical and medical organizations to advance Prothena’s clinical pipeline. “Hideki brings valuable experience and expertise to our team as we look ahead towards transitioning to a fully integrated research, development and commercial biotechnology company,” said Gene Kinney, PhD, President and Chief Executive Officer. “His experience leading several late-stage development programs in neurology and rare disease indications through registration and launch is...

Continue reading

iCAD Announces Estimated Q1 Revenues and Upcoming CFO Transition

Company expects preliminary estimated revenues to exceed $8.1 million Successor CFO search underway NASHUA, N.H., April 05, 2021 (GLOBE NEWSWIRE) — iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, reported select preliminary, unaudited financial results for the first quarter of 2021. Based on preliminary, unaudited financial information, the Company expects total revenue for the first quarter of 2021 to exceed $8.1 million. Unaudited cash and cash equivalents as of March 31, 2021 were approximately $46.9 million, which includes proceeds of the public offering closed in March 2021 that generated gross proceeds of approximately $25.0 million. “For the first quarter of 2021, anticipated final revenue numbers represent significant growth, compared to the first...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.